HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.
第一作者:
Scott R,Richmond
第一单位:
Department of Internal Medicine, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
作者:
主题词
动物(Animals);肉碱O-软脂酰转移酶(Carnitine O-Palmitoyltransferase);细胞系(Cell Line);剂量效应关系, 药物(Dose-Response Relationship, Drug);脂肪酸转运蛋白质类(Fatty Acid Transport Proteins);脂肪酸类(Fatty Acids);HIV蛋白酶抑制药(HIV Protease Inhibitors);人类(Humans);小鼠(Mice);肌纤维, 骨骼(Muscle Fibers, Skeletal);肌, 骨骼(Muscle, Skeletal);寡肽类(Oligopeptides);氧化还原(Oxidation-Reduction);吡啶类(Pyridines);嘧啶酮类(Pyrimidinones);利托纳韦(Ritonavir);磺胺类(Sulfonamides)
DOI
10.1016/j.bbalip.2010.01.007
PMID
20117238
发布时间
2021-10-20
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文